Casivirimab-imdevimab Inpatient Monitoring Requirements

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

3 posts / 0 new
Log in or register to post comments
Last post
Tue, 06/01/2021 - 14:50
#1
Haley Grunwald
Haley Grunwald's picture
Offline
Last seen: 2 years 7 months ago
Joined: 04/02/2020 - 16:29
Casivirimab-imdevimab Inpatient Monitoring Requirements

Good afternoon,

For those that are administering casivirimab-imdevimab inpatient, what monitoring requirements do you have in place? We are a pediatric institution looking to assess what level of care will be necessary for inpatient administration (med surg, IMCU, PICU, etc.)

Thank you,
Haley Grunwald, PharmD, BCPPS
Medication Safety & Quality Coordinator

Top